文献速递心境障碍

推动精神健康研究中负责任的产学研合作与有亲身经历者参与

Enabling responsible industry-academic collaboration in mental health research and the involvement of people with lived experience.
PubMed 文献 · Br J Psychiatry · 2026-10-07

本文基于英国研究与创新精神健康平台与国际制药公司尝试合作的经验,描述了早期非推广性合作因监管解释不确定、合同要求和跨司法辖区合规流程差异而延迟和受限。文章指出这些障碍可能排除有亲身经历者、收窄科学对话并减少创新与患者优先事项对齐的机会,呼吁监管框架区分推广活动与透明的竞争前科学交流。

要点

  • 监管与合规框架可阻碍早期、非推广性、多学科的探索性产学研合作。
  • 合作障碍可能排除有亲身经历者并收窄科学对话。
  • 需区分推广活动与透明的竞争前科学交流以促进负责任早期对话。

核心结论

  • 监管框架应更好区分推广活动与透明的竞争前科学交流,以促成学术界、医疗界、产业界与患者社群之间适度、包容且负责任的早期对话。

研究设计与样本

  • 本文为基于英国研究与创新精神健康平台尝试与国际制药公司合作经验的论述性文章,非原始研究。

主要发现

  • 合作因监管解释不确定、合同要求和跨司法辖区合规流程差异而延迟和受限。
  • 这些障碍可能排除有亲身经历者、收窄科学对话并减少创新与患者优先事项对齐的机会。

临床怎么用

  • 在精神健康研究中推动早期产学研合作时,应识别并区分推广活动与竞争前科学交流,采用透明且包容的流程纳入有亲身经历者。

局限性

  • 本文基于单一合作尝试的经验,未报告系统性研究数据或量化结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There is an urgent need for more effective and better-tolerated treatments for mental illness. Achieving this requires responsible collaboration between academia, healthcare professionals, industry and people with lived experience. However, regulatory and compliance frameworks can make early-stage, non-promotional collaboration difficult, particularly when discussions are exploratory and multidisciplinary. Drawing on experience from the UK Research and Innovation Mental Health Platform's attempted collaboration with an international pharmaceutical company, this article describes how engagement was delayed and constrained by uncertainty over regulatory interpretation, contractual requirements and differing compliance processes across jurisdictions. These barriers risk excluding people with lived experience, narrowing scientific dialogue and reducing opportunities to align innovation with patient priorities. Robust regulation remains essential to protect patients, maintain public trust and prevent inappropriate influence. However, frameworks should better distinguish promotional activity from transparent, pre-competitive scientific exchange enabling proportionate, inclusive and responsible early dialogue between academia, healthcare, industry and patient communities.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. McIntosh AM, McTernan M, Rae S, et al. Enabling responsible industry-academic collaboration in mental health research and the involvement of people with lived experience. Br J Psychiatry. 2026. PMID: 42841251. doi:10.1192/bjp.2026.10817

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。